Table of Contents
International Journal of Proteomics
Volume 2011, Article ID 578903, 13 pages
http://dx.doi.org/10.1155/2011/578903
Research Article

Proteomic Characterization of Cerebrospinal Fluid from Ataxia-Telangiectasia (A-T) Patients Using a LC/MS-Based Label-Free Protein Quantification Technology

1Department Biochemistry and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Dr., MS 4053, Indianapolis, IN 46202, USA
2Division of Pediatric Allergy and Immunology, Departments of Pediatrics, Medicine, and Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
3Division of Pediatric Neurology, Departments of Neurology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
4Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
5Research Department, A-T Children's Project, Coconut Creek, FL 33073, USA

Received 24 January 2011; Accepted 18 March 2011

Academic Editor: Visith Thongboonkerd

Copyright © 2011 Monika Dzieciatkowska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Boder and R. P. Sedgwick, “Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection,” Pediatrics, vol. 21, no. 4, pp. 526–554, 1958. View at Google Scholar
  2. E. Border, “Ataxia-telangiectasia: an overview,” in Ataxia-Telangiectasia: Genetics, Neuropathy, and Immunology of a Degenerative Disease of Childhood, R. A. Gatti and M. Swift, Eds., pp. 1–63, Alan R. Liss, New York, NY, USA, 1985. View at Google Scholar
  3. R. A. Gatti, E. Boder, H. V. Vinters, R. S. Sparkes, A. Norman, and K. Lange, “Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis,” Medicine, vol. 70, no. 2, pp. 99–117, 1991. View at Google Scholar · View at Scopus
  4. R. A. Gatti, “Ataxia-telangiectasia,” in The Genetic Basis of Human Cancer, B. Vogelstein and K. W. Kinzler, Eds., pp. 239–266, McGraw-Hill, New York, NY, USA, 2nd edition, 2002. View at Google Scholar
  5. S. Perlman, S. Becker-Catania, and R. A. Gatti, “Ataxia-telangiectasia: diagnosis and treatment,” Seminars in Pediatric Neurology, vol. 10, no. 3, pp. 173–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. H. H. Chun, X. Sun, S. A. Nahas et al., “Improved diagnostic testing for ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM protein expression,” Molecular Genetics and Metabolism, vol. 80, no. 4, pp. 437–443, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Shiloh, “ATM and related protein kinases: safeguarding genome integrity,” Nature Reviews Cancer, vol. 3, no. 3, pp. 155–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Savitsky, A. Bar-Shira, S. Gilad et al., “A single ataxia telangiectasia gene with a product similar to PI-3 kinase,” Science, vol. 268, no. 5218, pp. 1749–1753, 1995. View at Google Scholar · View at Scopus
  9. M. B. Kastan and D. S. Lim, “The many substrates and functions of ATM,” Nature Reviews Molecular Cell Biology, vol. 1, no. 3, pp. 179–186, 2000. View at Google Scholar · View at Scopus
  10. H. Tanaka, M. S. Mendonca, P. S. Bradshaw et al., “DNA damage-induced phosphorylation of the human telomere-associated protein TRF2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 43, pp. 15539–15544, 2005. View at Publisher · View at Google Scholar
  11. T. Uziel, Y. Lerenthal, L. Moyal, Y. Andegeko, L. Mittelman, and Y. Shiloh, “Requirement of the MRN complex for ATM activation by DNA damage,” EMBO Journal, vol. 22, no. 20, pp. 5612–5621, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Wang, D. Cortez, P. Yazdi, N. Neff, S. J. Elledge, and J. Qin, “BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures,” Genes and Development, vol. 14, no. 8, pp. 927–939, 2000. View at Google Scholar · View at Scopus
  13. M. Löbrich and P. A. Jeggo, “The two edges of the ATM sword: co-operation between repair and checkpoint functions,” Radiotherapy and Oncology, vol. 76, no. 2, pp. 112–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. R. E. Higgs, M. D. Knierman, V. Gelfanova, J. P. Butler, and J. E. Hale, “Comprehensive label-free method for the relative quantification of proteins from biological samples,” Journal of Proteome Research, vol. 4, no. 4, pp. 1442–1450, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. D. P. G. Fitzpatrick, J. S. You, K. G. Bemis, J. P. Wery, J. R. Ludwig, and M. Wang, “Searching for potential biomarkers of cisplatin resistance in human ovarian cancer using a label-free LC/MS-based protein quantification method,” Proteomics—Clinical Applications, vol. 1, no. 3, pp. 246–263, 2007. View at Publisher · View at Google Scholar
  16. M. Wang, J. You, K. G. Bemis, T. J. Tegeler, and D. P. G. Brown, “Label-free mass spectrometry-based protein quantification technologies in proteomic analysis,” Briefings in Functional Genomics and Proteomics, vol. 7, no. 5, pp. 329–339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. W. J. McBride, J. A. Schultz, M. W. Kimpel et al., “Differential effects of ethanol in the nucleus accumbens shell of alcohol-preferring (P), alcohol-non-preferring (NP) and Wistar rats: a proteomics study,” Pharmacology Biochemistry and Behavior, vol. 92, no. 2, pp. 304–313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Nakshatri, G. Qi, J. You et al., “Intrinsic subtype-associated changes in the plasma proteome in breast cancer,” Proteomics—Clinical Applications, vol. 3, no. 11, pp. 1305–1313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. E. Hale, J. P. Butler, V. Gelfanova, J. You, and M. D. Knierman, “A simplified procedure for the reduction and alkylation of cysteine residues in proteins prior to proteolytic digestion and mass spectral analysis,” Analytical Biochemistry, vol. 333, no. 1, pp. 174–181, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Blennow, H. Hampel, M. Weiner, and H. Zetterberg, “Cerebrospinal fluid and plasma biomarkers in Alzheimer disease,” Nature Reviews Neurology, vol. 6, no. 3, pp. 131–144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Korolainen, T. A. Nyman, T. Aittokallio, and T. Pirttilä, “An update on clinical proteomics in Alzheimer's research,” Journal of Neurochemistry, vol. 112, no. 6, pp. 1386–1414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. C. Kroksveen, J. A. Opsahl, T. T. Aye, R. J. Ulvik, and F. S. Berven, “Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics,” Journal of Proteomics, vol. 74, no. 4, pp. 371–388, 2011. View at Publisher · View at Google Scholar
  23. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar
  24. R. E. Higgs, M. D. Knierman, A. B. Freeman, L. M. Gelbert, S. T. Patil, and J. E. Hale, “Estimating the statistical significance of peptide identifications from shotgun proteomics experiments,” Journal of Proteome Research, vol. 6, no. 5, pp. 1758–1767, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. B. M. Bolstad, R. A. Irizarry, M. Åstrand, and T. P. Speed, “A comparison of normalization methods for high density oligonucleotide array data based on variance and bias,” Bioinformatics, vol. 19, no. 2, pp. 185–193, 2003. View at Publisher · View at Google Scholar
  26. N. McTavish, L. A. Copeland, M. K. Saville, N. D. Perkins, and B. A. Spruce, “Proenkephalin assists stress-activated apoptosis through transcriptional repression of NF-κB- and p53-regulated gene targets,” Cell Death and Differentiation, vol. 14, no. 9, pp. 1700–1710, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. J. Augood, R. L. Faull, D. R. Love, and P. C. Emson, “Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study,” Neuroscience, vol. 72, no. 4, pp. 1023–1036, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Zhu, J. T. Robertson, H. S. Sacks, F. C. Dohan Jr, J. L. Tseng, and D. M. Desiderio, “Opioid and tachykinin neuropeptides in prolactin-secreting human pituitary adenomas,” Peptides, vol. 16, no. 6, pp. 1097–1107, 1995. View at Publisher · View at Google Scholar
  29. B. K. Brar and P. J. Lowry, “The differential processing of proenkephalin A in mouse and human breast tumour cell lines,” Journal of Endocrinology, vol. 161, no. 3, pp. 475–484, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Heagy, E. Teng, P. Lopez, and R. W. Finberg, “Enkephalin receptors and receptor-mediated signal transduction in cultured human lymphocytes,” Cellular Immunology, vol. 191, no. 1, pp. 34–48, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Sercu, L. Zhang, and J. Merregaert, “The extracellular matrix protein 1: its molecular interaction and implication in tumor progression,” Cancer Investigation, vol. 26, no. 4, pp. 375–384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Chan, L. Liu, T. Hamada, G. Sethuraman, and J. A. Mcgrath, “The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1,” Experimental Dermatology, vol. 16, no. 11, pp. 881–890, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. F. Ofori-Acquah and J. A. King, “Activated leukocyte cell adhesion molecule: a new paradox in cancer,” Translational Research, vol. 151, no. 3, pp. 122–128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Cayrol, K. Wosik, J. L. Berard et al., “Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system,” Nature Immunology, vol. 9, no. 2, pp. 137–145, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. F. R. Burns, S. Von Kannen, L. Guy, J. A. Raper, J. Kamholz, and S. Chang, “DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension,” Neuron, vol. 7, no. 2, pp. 209–220, 1991. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Kahlert, H. Weber, C. Mogler et al., “Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse,” British Journal of Cancer, vol. 101, no. 3, pp. 457–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Horst, L. Kriegl, J. Engel, T. Kirchner, and A. Jung, “Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer,” Cancer Investigation, vol. 27, no. 8, pp. 844–850, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. W. C. Shyu, S. Z. Lin, M. F. Chiang et al., “Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke,” Journal of Clinical Investigation, vol. 118, no. 1, pp. 133–148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Stridsberg, B. Eriksson, and E. T. Janson, “Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours,” Regulatory Peptides, vol. 148, no. 1–3, pp. 95–98, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Schrott-Fischer, M. Bitsche, C. Humpel et al., “Chromogranin peptides in amyotrophic lateral sclerosis,” Regulatory Peptides, vol. 152, no. 1–3, pp. 13–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. W. Ruan, E. Xu, F. Xu et al., “IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis,” Cancer Biology and Therapy, vol. 6, no. 3, pp. 354–359, 2007. View at Google Scholar · View at Scopus
  42. I. Bièche, F. Lerebours, S. Tozlu, M. Espie, M. Marty, and R. Lidereau, “Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature,” Clinical Cancer Research, vol. 10, no. 20, pp. 6789–6795, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. W. H. McDonald and J. R. Yates III, “Shotgun proteomics and biomarker discovery,” Disease Markers, vol. 18, no. 2, pp. 99–105, 2002. View at Google Scholar · View at Scopus
  44. C. C. Wu, M. J. MacCoss, K. E. Howell, and J. R. Yates III, “A method for the comprehensive proteomic analysis of membrane proteins,” Nature Biotechnology, vol. 21, no. 5, pp. 532–538, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. M. P. Washburn, R. Ulaszek, C. Deciu, D. M. Schieltz, and J. R. Yates III, “Analysis of quantitative proteomic data generated via multidimensional protein identification technology,” Analytical Chemistry, vol. 74, no. 7, pp. 1650–1657, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. M. P. Washburn, D. Wolters, and J. R. Yates III, “Large-scale analysis of the yeast proteome by multidimensional protein identification technology,” Nature Biotechnology, vol. 19, no. 3, pp. 242–247, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. W. Yan and S. S. Chen, “Mass spectrometry-based quantitative proteomic profiling,” Briefings in Functional Genomics and Proteomics, vol. 4, no. 1, pp. 27–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. S. P. Gygi, B. Rist, S. A. Gerber, F. Turecek, M. H. Gelb, and R. Aebersold, “Quantitative analysis of complex protein mixtures using isotope-coded affinity tags,” Nature Biotechnology, vol. 17, no. 10, pp. 994–999, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. A. K. Cheema, O. Timofeeva, R. Varghese et al., “Integrated analysis of ATM mediated gene and protein expression impacting cellular metabolism,” Journal of Proteome Research, vol. 10, no. 5, pp. 2651–2657, 2011. View at Google Scholar
  50. M. Bantscheff, M. Schirle, G. Sweetman, J. Rick, and B. Kuster, “Quantitative mass spectrometry in proteomics: a critical review,” Analytical and Bioanalytical Chemistry, vol. 389, no. 4, pp. 1017–1031, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. S. K. Huang, M. M. Darfler, M. B. Nicholl et al., “LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis,” PLoS ONE, vol. 4, no. 2, article e4430, pp. 1–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. D. B. Mendis and I. R. Brown, “Expression of the gene encoding the extracellular matrix glycoprotein SPARC in the developing and adult mouse brain,” Molecular Brain Research, vol. 24, no. 1–4, pp. 11–19, 1994. View at Publisher · View at Google Scholar · View at Scopus
  53. D. B. Mendis, G. O. Ivy, and I. R. Brown, “SPARC/osteonectin mRNA is induced in blood vessels following injury to the adult rat cerebral cortex,” Neurochemical Research, vol. 23, no. 8, pp. 1117–1123, 1998. View at Publisher · View at Google Scholar · View at Scopus
  54. D. B. Mendis, L. Malaval, and I. R. Brown, “SPARC, an extracellular matrix glycoprotein containing the follistatin module, is expressed by astrocytes in synaptic enriched regions of the adult brain,” Brain Research, vol. 676, no. 1, pp. 69–79, 1995. View at Publisher · View at Google Scholar · View at Scopus
  55. M. S. Riedl, P. D. Braun, K. F. Kitto et al., “Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing,” Journal of Neuroscience, vol. 29, no. 42, pp. 13377–13388, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Bernay, M. C. Gaillard, V. Guryca et al., “Discovering new bioactive neuropeptides in the striatum secretome using in vivo microdialysis and versatile proteomic,” Molecular and Cellular Proteomics, vol. 8, no. 5, pp. 946–958, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. G. M. Pasinetti, L. H. Ungar, D. J. Lange et al., “Identification of potential CSF biomarkers in ALS,” Neurology, vol. 66, no. 8, pp. 1218–1222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Kousi, E. Siintola, L. Dvorakova et al., “Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis,” Brain, vol. 132, no. 3, pp. 810–819, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Kibe, G. A. Osawa, C. E. Keegan, and T. de Lange, “Telomere protection by TPP1 is mediated by POT1a and POT1b,” Molecular and Cellular Biology, vol. 30, no. 4, pp. 1059–1066, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. X. Qi, L. Sun, A. S. Lewin, W. W. Hauswirth, and J. Guy, “Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy,” Investigative Ophthalmology and Visual Science, vol. 48, no. 12, pp. 5360–5370, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. Z. Guo, S. Kozlov, M. F. Lavin, M. D. Person, and T. T. Paull, “ATM activation by oxidative stress,” Science, vol. 330, no. 6003, pp. 517–521, 2010. View at Publisher · View at Google Scholar